MedImmune And National Institutes Of Health Begin Clinical Testing Of A Live, Attenuated Intranasal Vaccine Against An H5N1 Avian Influenza Virus
submited by kickingbird at Jun, 16, 2006 16:18 PM from Medical News Today
MedImmune, Inc.(Nasdaq: MEDI) announced today that the National Institutes of Health (NIH)has begun enrolling participants in a Phase 1 study of an intranasal H5N1influenza vaccine candidate based on the company´s live, attenuated vaccinetechnology. [click link for full article]
See Also:
Latest news in those days:
- USDA: HPAI detection in Wyoming (wild birds and mammals) 5 hours ago
- USDA: HPAI detection in Washington (wild birds and mammals) 5 hours ago
- USDA: HPAI detection in Oregon 5 hours ago
- USDA: HPAI detection in Idaho 5 hours ago
- USDA: HPAI detection in Texas 5 hours ago
[Go Top] [Close Window]


